Safety and Outcome of Retreatment with [177Lu]LuPSMA-I&T Radioligand Therapy (PRLT) in Metastatic Castration Resistant Prostate Cancer

被引：0
|
作者：
Santo, G. [1 ,2 ]
Di Santo, G. [1 ]
Sviridenko, A. [1 ]
Kiasatdolatabadi, M. [1 ]
Bayerschmidt, S. [1 ]
Wirth, L. [1 ]
Scherbauer, F. [1 ]
Lehmann, P. [1 ]
von Guggenberg, E. [1 ]
Decristoforo, C. [1 ]
Virgolini, I. [1 ]
机构：
[1] Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria
[2] Magna Graecia Univ Catanzaro, Catanzaro, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-274
引用
收藏
页码：S418 / S419
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer
    Santo, Giulia
    Santo, Gianpaolo Di
    Sviridenko, Anna
    Bayerschmidt, Steffen
    Wirth, Lukas
    Scherbauer, Fabian
    Lehmann, Peter
    von Guggenberg, Elisabeth
    Decristoforo, Clemens
    Heidegger-Pircher, Isabel
    Bektic, Jasmin
    Virgolini, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 52 (01) : 354 - 365
  • [2] Treatment of castration-resistant metastatic prostate cancer with [177Lu]PSMA radioligand
    Sundset, Rune
    Haugnes, Hege Sagstuen
    Perez, Alexander
    Engelsen, Ola
    Fosseide, Ida H. H.
    Castillejo, Miguel J.
    Bogsrud, Trond Velde
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (09)
  • [3] 177Lu -PSMA-I&T PSMA radioligand therapy in metastatic castration - resistant prostate cancer: First clinical trial in Asia
    Bu, Ting
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S527 - S528
  • [4] Effectiveness of 177Lu PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Gunalp, Bengul
    Emer, Mustafa
    Ozaydin, Sukru
    Alagoz, Engin
    Ince, Semra
    Ayan, Asli
    Alkan, Sumeyye
    Mahmudov, Sarkhan
    Okuyucu, Kursat
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [5] Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
    Heck, Matthias M.
    Tauber, Robert
    Schwaiger, Sebastian
    Retz, Margitta
    D'Alessandria, Calogero
    Maurer, Tobias
    Gafita, Andrei
    Wester, Hans-Juergen
    Gschwend, Juergen E.
    Weber, Wolfgang A.
    Schwaiger, Markus
    Knorr, Karina
    Eiber, Matthias
    EUROPEAN UROLOGY, 2019, 75 (06) : 920 - 926
  • [6] Personalized dosimetry assessment of [177Lu]Lu-PSMA-617 radioligand therapy in the management of metastatic castration-resistant prostate cancer
    Kazemi-Jahromi, Mahmood
    Yazdani, Elmira
    Karamzade-Ziarati, Najme
    Asadi, Mahboobeh
    Sadeghi, Mahdi
    Geramifar, Parham
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2024, 100 (11) : 1551 - 1559
  • [7] Systemic radioligand therapy with 177Lu-PSMA I&T in patients with metastatic castration-resistant prostate cancer
    Eiber, Matthias
    Heck, Matthias
    Tauber, Robert
    Rauscher, Isabel
    D'Alessandria, Calogero
    Maurer, Tobias
    Retz, Margitta
    Wester, Hans
    Schwaiger, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [8] Systemic Radioligand Therapy with 177Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer
    Heck, Matthias M.
    Retz, Margitta
    D'Alessandria, Calogero
    Rauscher, Isabel
    Scheidhauer, Klemens
    Maurer, Tobias
    Storz, Enno
    Janssen, Friederike
    Schottelius, Margret
    Wester, Hans-Juergen
    Gschwend, Juergen E.
    Schwaiger, Markus
    Tauber, Robert
    Eiber, Matthias
    JOURNAL OF UROLOGY, 2016, 196 (02): : 382 - 390
  • [9] Safety and Efficacy of [177Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
    Tauber, Robert
    Knorr, Karina
    Retz, Margitta
    Rauscher, Isabel
    Grigorascu, Sonia
    Hansen, Kimberley
    D'Alessandria, Calogero
    Wester, Hans-Jurgen
    Gschwend, Jurgen
    Weber, Wolfgang
    Eiber, Matthias
    Langbein, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (08) : 1244 - 1251
  • [10] Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy
    Ahmadzadehfar, Hojjat
    Schlolaut, Stephan
    Fimmers, Rolf
    Yordanova, Anna
    Hirzebruch, Stefan
    Schlenkhoff, Carl
    Gaertner, Florian C.
    Awang, Zool Hilmi
    Hauser, Stefan
    Essler, Markus
    ONCOTARGET, 2017, 8 (61) : 103108 - 103116
12345